Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 26, 2002
[Lethal arrhythmias--etiological view and therapeutic approach]Takeshi Ueyama, Kohshiro Moritani, Akihiko Shimizu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 28, 2003
Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzolineHiroyuki Kakugawa, Akihiko Shimizu, Toshihiko Yamagata, et al.
Journal of Cardiovascular Electrophysiology|September 3, 2003
New method of determining the atrial fibrillation cycle length during human atrial fibrillationAkihiko Shimizu, Toshihiko Yamagata, Masahiro Esato, et al.
Immunity & Ageing : I & A|August 17, 2023
Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: a prospective longitudinal study in JapanTomoyuki Kakugawa, Keiko Doi, Yuichi Ohteru, et al.
Immunity & Ageing : I & A|June 22, 2024
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in JapanTomoyuki Kakugawa, Yusuke Mimura, Yuka Mimura-Kimura, et al.
Cardiovascular Drugs and Therapy|September 16, 2004
Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainideMasashi Kanemoto, Akihiko Shimizu, Toshihiko Yamagata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 9, 2003
Effects of flecainide on the electrophysiological properties of atrial vulnerability in humansYasuhiro Yoshiga, Akihiko Shimizu, Toshihiko Yamagata, et al.
Pageof 1